Fecal immunochemical test screening found to lower risk of death from colorectal cancer

Screening with fecal immunochemical tests (FITs) lowers the risk of dying from colorectal cancer (CRC), according to a study published online July 19 in JAMA Network Open. Chyke A. Doubeni, M.D., from The Ohio State University College of Medicine in Columbus, and colleagues evaluated whether FIT screening is associated with a lower risk of dying from CRC overall, as well as by cancer location and demographic group. Analysis included 1,103 people (aged 52 to 85 years) who died from colorectal adenocarcinoma between 2011 and 2017 (cases) and 9,608 controls matched (1:8) based on age, sex, health-plan membership duration, and geographic Read More